NCT07038343View on ClinicalTrials.gov

Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

430

Participants

Timeline

Start Date

June 4, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

December 31, 2030

Conditions
Solid Tumor CancerLocally AdvancedMetastatic Solid TumorsLung CancersEpithelial Tumor
Interventions
DRUG

AVZO-1418

Specific dose in protocol specified schedule

DRUG

Combination Agent 1

Per label based on combination agent used

DRUG

Combination Agent 2

Per label based on combination agent used

Trial Locations (8)

22031

RECRUITING

Avenzo Therapeutics Recruiting Site, Fairfax

32827

RECRUITING

Avenzo Therapeutics Recruiting Site, Orlando

34232

RECRUITING

Avenzo Therapeutics Recruiting Site, Sarasota

75039

RECRUITING

Avenzo Therapeutics Recruiting Site, Dallas

77054

RECRUITING

Avenzo Therapeutics Recruiting Site, Houston

78229

RECRUITING

Avenzo Therapeutics Recruiting Site, San Antonio

80218

RECRUITING

Avenzo Therapeutics Recruiting Site, Denver

84119

RECRUITING

Avenzo Therapeutics Recruiting Site, West Valley City

Sponsors
All Listed Sponsors
lead

Avenzo Therapeutics, Inc.

INDUSTRY